Drugs / Ferrous sulfate tablets
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04268849 Comparator | Feb 2020 → Nov 2025 overdue | iron deficiency anemia | Auerbach Hematology Oncology Associates P C | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ferrous sulfate tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04268849 ↗ |
| Route | Oral | “oral ferrous sulfate” NCT04268849 ↗ |